
The Crowd: Exhibit recalls when Bob's was big on Balboa Island's Marine Avenue
Lines of locals and tourists alike stepped up to the street-front counter to order their prized Bob's burger and an 'extra thick' shake. Add hot fries (perhaps with blue cheese dressing on the side for dipping purposes) and it was the ideal treat for strolling Marine Avenue and then finding a bench or cement wall on the bayfront to take in the view and share burgers.
All of those memories come rushing back as museum curator and executive director of Balboa Island Museum, Tiffany Pepys Hoey, collected and assembled a photo display along with narration on the history of the fast-food business on Balboa Island before all the big chains such as McDonald's became American fast-food phenomena. Bob's, (originally called Bob's Pantry) founded by Bob Wian and his team in 1936, first opened in Glendale. It was built by Bob Peterson (father of Balboa Island local Judy Tucker); the business eventually expanded to more than 240 locations.
The Wian family lived in the Los Angeles area and also had a beach home in Newport and loved life on Balboa Island. Bob's was located in the orange-colored building in the 300 block of Marine Avenue in the 1960s. Bob Wian was often in the Island store greeting visiting customers and neighbors alike. The business was sold in 1967 to Marriott Corporation. Today, four Bob's locations still serve customers in Southern California: Burbank, Downey, Norco and Northridge.
Credited with creating the three-decker hamburger, Wian's sandwich quickly became a hit, but it had yet to be named. According to restaurant lore, a chubby 6-year-old named Richard Woodruff had been doing chores at Bob's Pantry in exchange for free burgers. When Wian called him 'Big Boy,' the name stuck, and the rest is hamburger history.
Another regular customer, Ben Washam, a movie studio animator for Warner Bros., sketched the now famous character on a napkin. The Big Boy burger craze that ensued prompted Bob Wian to change the diner's name to Bob's Big Boy and to introduce the now-iconic Big Boy mascot.
Among the special items on display in the museum gallery is an original statue of 'Bob' on loan to the museum from a local collector on Balboa Island. Balboa Island Museum staff produced a lively hamburger-themed open house as museum members and guests poured in for the recent mid-week opening catered by museum board member Cynthia Shafer, talented restaurateur and proprietor of the Royal Hen on the Island.
Burgers, fries, and ice cream treats delighted the crowd sharing memories. Checking out the photographic and memorabilia display in the main Gallery were Museum chief executive Shirley Pepys, John Conners, president of the museum board and his wife, Diana; Sue Sibley, Renee Pepys Lowe and Christine Tillet. Also there were John Scudder, Jim and Erin Moloney, Andrea and Tom McElroy, Bob and Kim Miller and Jack Callahan.
The exhibit will run through June and into July, open free to the public daily. For more information, visit balboaislandmuseum.org.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
a minute ago
- Business Wire
Burger King® Introduces the Latest 'Whopper® by You' With a Crispy Onion Twist on the Classic
MIAMI--(BUSINESS WIRE)--Following the BBQ Brisket Whopper – the first innovation in the newly launched 'Whopper by You' platform – Burger King is giving Guests an all-new take on the flame-grilled classic inspired by their cravings, and it's a bacon and onion lover's dream. With layers on layers of flavor, the Crispy Onion Whopper is the ultimate mix of sweet, savory and crunch that BK fans have been asking for. The Crispy Onion Whopper features more than ¼ lb.** of beef flame-grilled to perfection topped with crisp lettuce, juicy tomatoes, creamy mayo, melty American cheese, bacon and crunchy pickles with golden onion rings, crispy onions and a sweet & smoky BBQ sauce. For a smaller taste of crunchy, onion-y deliciousness, BK is also offering the latest Whopper innovation as a Whopper Jr. – similar to the BBQ Brisket Whopper. 'Burger King Guests have been loving the recently launched BBQ Brisket Whopper, so we're excited to bring another Guest-inspired creation to our menus,' said Joel Yashinsky, Chief Marketing Officer, Burger King US&C. 'Like the BBQ Brisket Whopper, the Crispy Onion Whopper is a result of listening to our Guests, and we can't wait to see what else they come up with that could make its way to BK restaurants in the future.' Guests can continue to share their next great Whopper innovations via the 'Whopper by You' platform by visiting With each qualifying submission, Guests can redeem one of several special Royal Perks rewards assigned at random, including $0.01 Whopper sandwich each week for a year, free hamburgers, cheeseburgers, or Whopper Jr. sandwiches with purchase, and more.*** To find your nearest Burger King restaurant or to learn more about the new BBQ Brisket Whopper and 'Whopper by You' platform, visit *Limited time at participating US restaurants, while supplies last. **Weight based on pre-cooked patty ***Royal Perks account registration required. Must be 18+. U.S. only. Terms apply. See ABOUT BURGER KING ® Founded in 1954, the Burger King ® brand is a global quick service hamburger chain known for food quality and value and as the only place guests can get the iconic flame-grilled Whopper ® sandwich. The Burger King system operates more than 19,000 locations in more than 120 countries and U.S. territories. Nearly all Burger King® restaurants are owned and operated by independent franchisees, many of them family-owned operations that have been in business for decades. To learn more about the Burger King brand, please visit the official brand website at or the newsroom at and follow us on Facebook, Instagram, X and TikTok.


NBC News
2 minutes ago
- NBC News
Target names longtime insider Michael Fiddelke its next CEO as retailer tries to break sales and stock slump
Target on Wednesday said that company veteran Michael Fiddelke will become its next CEO at a critical point in its effort to break out of a sales slump and win back Wall Street's favor. Fiddelke, the company's 49-year-old chief operating officer and former chief financial officer, will succeed Brian Cornell effective Feb. 1. Cornell, who took the helm of the cheap chic retailer in 2014, will transition to the role of executive chair on Target's board of directors. The Minneapolis-based retailer made the announcement on the same day it reported fiscal second-quarter results. It topped Wall Street's quarterly sales and earnings expectations, but stuck by a full-year outlook that forecasts another annual sales decline. Target shares dropped about 10% in premarket trading after the company made the CEO announcement and released results. Before Target announced its choice, Wall Street appeared to favor an outsider for the top job. Fiddelke steps into Target's top role as the big-box retailer tries to find its footing and get back to growth. Target's annual sales have been roughly flat for the past four years after the company's sales soared during the Covid pandemic. On a call with reporters, Fiddelke said he is 'stepping in with urgency to rebuild momentum and return to profitable growth.' He laid out three priorities: Reestablishing Target's reputation as a retailer with stylish and unique items, providing a more consistent customer experience and using technology more effectively to operate an efficient business. 'We've built a solid foundation, and we're proud of the many ways that Target is unique in American retail,' he said. 'We also have real work in front of us.' Fiddelke is a 20-year Target veteran. During his decades with the company, he has held leadership roles across merchandising, finance, operations and human resources. He became Target's chief financial officer in late 2019 and stepped into the role of chief operating officer in early 2024. In May, he was tapped to oversee a new effort, the Enterprise Acceleration Office, created to turn around Target's results. Target cut its full-year outlook in May and reiterated that guidance on Wednesday, saying that it expects a low-single-digit percentage point decline in sales this fiscal year. Target's performance has shaken Wall Street's confidence. Shares of the company have tumbled about 60% since their all-time high in 2021. Target's stock had dropped 22% in 2025 alone as of Tuesday's close. Customers, former employees and suppliers told CNBC that the company's best-known traits of eye-catching merchandise, tidy stores and friendly employees have become weaker. The retailer also is facing stiffer competition from rivals including Walmart, contending with cost pressures because of tariffs and dealing with backlash to its reversal of key diversity, equity and inclusion policies. And last week, Ulta Beauty and Target announced they are ending a deal that opened mini beauty shops in nearly a third of Target's stores. The partnership will end in August 2026. Wall Street had favored an outsider for the CEO job, according to a June survey of 51 investors by Mizuho Securities, an equity research firm. About 96% of investors polled favored an external hire for Target's next CEO. Christine Leahy, lead independent director of Target's board of directors, said in a news release that the board chose Fiddelke after 'an extensive external search and assessment of many strong candidates' over several years. 'Michael's tenure gives him unmatched enterprise insight and a base of strong team trust,' she said. 'But what sets him apart is how he combines those strengths with a 'fresh eyes' mindset, challenging the status quo to evolve how the business operates, differentiates and delivers long-term value.' On a call with reporters, Cornell and Fiddelke were asked what they would say to investors who had hoped for Target to hire an outsider who would bring fresh ideas. Fiddelke answered the question. 'I understand this business,' he said. 'I understand what makes Target distinctly unique. And I've seen us at our best, and I've seen us when we're not at our best, and that informs my candid assessment today of where we have work to do as well.' 'But I'll go back to some of what I started with: My number one goal is to get us back to growth.'


Business Wire
31 minutes ago
- Business Wire
ClearStrand-ASD, First-of-Its-Kind Autism Screening Tool, Now Available in Japan
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-- LinusBio, a leader in precision exposome medicine, announced today that ClearStrand-ASD™, its biochemical autism screening test, is now available to patients and providers in Japan for research use through its partnership with YAC Bio. This milestone marks LinusBio's first international expansion and represents a significant step in the company's mission to enable earlier identification of autism spectrum disorder (ASD) globally. Today marks a transformational moment in our mission to make early autism screening accessible worldwide. Share ClearStrand-ASD requires only a strand of hair to detect molecular signatures associated with autism spectrum disorder. This innovative, non-invasive approach provides healthcare providers with an objective screening method that can help identify ASD risk as early as one month of age, allowing families to pursue intervention during the most crucial period of early development. "Today marks a transformational moment in our mission to make early autism screening accessible worldwide," said Dr. Manish Arora, Founder and CEO of LinusBio. "Japan represents our first step beyond U.S. borders, and we chose this market because of its sophisticated healthcare infrastructure and commitment to pediatric developmental care. Japanese families dealing with autism concerns will now have access to the same cutting-edge screening technology that has already helped multiple American families get answers earlier than ever before." The Japanese launch builds on ClearStrand-ASD's successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate the implementation of this first-of-its-kind biomarker test for autism. LinusBio's expansion into Japan is facilitated through its existing partnership with YAC Bio (part of Y.A.C. Holdings), the Japanese multinational that invested over 1 billion yen in the company. Beyond providing market access, Y.A.C. Holdings contributes manufacturing expertise and automation capabilities that support LinusBio's scaling efforts globally. "By combining the world's only hair-cutting robotics technology with the innovative hair exposome analysis developed by LinusBio in the United States, we have contributed to the development of the world's first biomarker screening test for autism spectrum disorder. Following its launch in the U.S., we are now offering this test in Japan through our group company, YAC Bio," said Takefumi Momose, President and CEO, Y.A.C. Holdings Co., Ltd. "We sincerely hope that this test will support individuals, families, and communities in Japan who are concerned about autism." The Japan availability of ClearStrand-ASD represents the first phase of LinusBio's international expansion strategy, with the company evaluating additional markets where ClearStrand-ASD could address unmet needs in early autism detection. About ClearStrand-ASD ClearStrand-ASD is a biochemical test intended to help health care providers rule out autism spectrum disorder (ASD) in children 1 to 48 months. The test analyzes a strand of hair to map the dynamic patterns of an individual's unique biological responses at a molecular level to environmental exposures over time and uses an algorithm to assess the likelihood of autism. It is not a genetic test and must be ordered by a licensed health care provider (Rx only). ClearStrand-ASD is performed at LinusBio's CLIA-certified laboratory (CLIA #31d2307499). For more information visit: About LinusBio LinusBio (Linus Biotechnology Inc.) is a patient-centric, breakthrough science precision exposome medicine company headquartered in New Jersey. The Company's program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology. LinusBio is actively exploring additional international partnerships to expand global access to its innovative diagnostic solutions. For more information, visit About Y.A.C. Holdings Y.A.C. Holdings is a Japan-based company specializing in developing, designing, and manufacturing mechatronics-related products. The company collaborates with LinusBio on hardware innovations to scale testing capacity, driving breakthroughs in robotics and laboratory automation.